Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
08/2009
08/27/2009US20090214636 Imaging and Therapeutic Method Using Monocytes
08/27/2009US20090214635 Identification of a conserved region of plasmodium falciparum msp3 targeted by biologically active antibodies
08/27/2009US20090214633 Nanoparticles with lipid core and polymer shell structures for protein drug delivery prepared by nanoencapsulation
08/27/2009US20090214632 Inducing cellular immune responses to human papillomavirus using peptide and nucleic acid compositions
08/27/2009US20090214620 Agent for use in the case of disorders of blood sugar metabolism, including diabetes
08/27/2009US20090214619 Implant for intraocular drug delivery
08/27/2009US20090214616 Biomaterials having nanoscale layers and coatings
08/27/2009US20090214612 Extracellular tnf inhibitors for treating cns disorders
08/27/2009US20090214605 Hydrophilic Core Polymeric Micelles for the Delivery of Water-Soluble Compounds
08/27/2009US20090214603 Synthetic peptides
08/27/2009US20090214598 Monovalent and polyvalent synthetic polysaccharide antigens for immunological intervention in disease
08/27/2009US20090214581 Epitope peptides derived from vascular endothelial growth factor receptor 1 and vaccines containing these peptides
08/27/2009US20090214580 Peptide mixtures with immunomodulatory activity
08/27/2009US20090214576 Tyrosine kinase inhibitor compositions and methods for manufacturing and using them in the treatment of disease
08/27/2009US20090214575 Annexin II and uses thereof
08/27/2009US20090214573 Modulation of bne development
08/27/2009US20090214572 Methods and compositions for the treatment and diagnosis of endothelial cell disorders and angiogenic disorders
08/27/2009US20090214563 Treatment for antiphospholipid-syndrome-related pregnancy complications
08/27/2009US20090214554 Truncated memapsin 2 compositions and treatments
08/27/2009US20090214552 Novel Egg Receptors for Sperm Proteins
08/27/2009US20090214550 Identification of Surface-Associated Antigens for Tumor Diagnosis and Therapy
08/27/2009US20090214548 TGR3-Like Protein Receptor
08/27/2009US20090214540 Protein involved in cancer
08/27/2009US20090214538 Use of complement inhibitors to treat ocular diseases
08/27/2009US20090214537 Serum Resistance Factors of Gram Positive Bacteria
08/27/2009US20090214536 CACNA1E in Cancer Diagnosis, Detection and Treatment
08/27/2009US20090214532 ANKTM1, A Cold-Activated TRP-Like Channel Expressed in Nociceptive Neurons
08/27/2009US20090214521 Bone morphogenetic protein-2 in the treatment and diagnosis of cancer
08/27/2009US20090214520 Soluble CLCA-1 and antagonists to CLCA-1
08/27/2009US20090214514 Gus3 neuropeptides for regulating hypothalamic function
08/27/2009US20090214513 Mammalian expression systems
08/27/2009US20090214512 Methods of treating skin disease, scalp disease, sensitive skin or suppressing hair loss with microbubble washing compositions
08/27/2009US20090214511 Digestible compositions of inulin for managing blood glucose levels
08/27/2009US20090214510 Broad Spectrum Antiviral Compositions
08/27/2009US20090214508 Vegf-activated fas ligands
08/27/2009US20090214507 Method of treating preventing, inhibiting or reducing damage to cardiac tissue
08/27/2009US20090214506 Use of TFPI to Treat Severe Bacterial Infections
08/27/2009US20090214505 For treating an excess of a substrate for a hyaluronidase, such as reducing scar tissue
08/27/2009US20090214498 Antimicrobial peptides and bacterial strains that produce them
08/27/2009US20090214496 Bmx/etk tyrosine kinase gene therapy materials and methods
08/27/2009US20090214495 Vascular endothelial growth factor-d (vegf)-d and functionally fragments thereof for bone repairing
08/27/2009US20090214492 Isolated stromal cells for use in the treatment of diseases of the central nervous system
08/27/2009US20090214489 Peptides and compounds that bind to a receptor
08/27/2009US20090214480 Novel cancer antigen peptide and the use thereof
08/27/2009US20090214476 Novel mannose-specific adhesins and their use
08/27/2009US20090214474 Compounds, methods, and treatments for abnormal signaling pathways for prenatal and postnatal development
08/27/2009US20090214473 Combination chaperonin 10 and beta-interferon therapy for multiple sclerosis
08/27/2009US20090214472 Interferon-beta polymer conjugates
08/27/2009US20090214471 Use of pegylated il-10 to treat cancer
08/27/2009US20090214470 Eye-drop vaccine containing copolymer 1 for therapeutic immunization
08/27/2009US20090214469 Methods and Compositions for the Treatment of Sepsis
08/27/2009US20090214468 bone implants; for non-diabetic patients
08/27/2009US20090214467 Methods of protecting against apoptosis using lipopeptides
08/27/2009US20090214466 Methods of Alleviating Disorders and Their Associated Pain
08/27/2009US20090214465 Quinoxaline Derivatives as Antitumor Agents
08/27/2009US20090214464 Compounds for flaviviridae treatment
08/27/2009US20090214463 Latent phase viral interleukin-10-(VII-10) and uses thereof
08/27/2009US20090214438 Methods and compositions for the preparation and use of toxin conjugates
08/27/2009US20090214431 Identification of ergothioneine transporter and therapeutic uses thereof
08/27/2009US20090214430 Polypeptide specifically bound to phosphatidylserine and the use thereof
08/27/2009US20090214429 Methods and compositions related to targeting tumors and wounds
08/27/2009US20090214427 Novel peptides
08/27/2009US20090214424 Human glycoprotein hormone superagonists and uses thereof
08/27/2009US20090214422 DNA encoding a novel RG1 polypeptide
08/27/2009US20090214419 Self-assembled biodegradable polymersomes
08/27/2009DE202008017456U1 Flüssig-Formulierung von G-CSF-Konjugaten Liquid formulation of G-CSF Conjugates
08/27/2009CA2752851A1 Treatment and prevention of dry age-related macular degeneration by activating cd36
08/27/2009CA2718588A1 Complement inhibitors as therapeutic agents for treatment of cancer
08/27/2009CA2716509A1 Method for treatment of photosensitivity and phototoxicity
08/27/2009CA2716392A1 Mntf peptide compositions and methods of use
08/27/2009CA2716255A1 Cosmetic and dermatological formulations of mntf peptides
08/27/2009CA2716185A1 Compositions and methods for treating ophthalmic diseases
08/27/2009CA2716007A1 Mimotope
08/27/2009CA2715940A1 Oligopeptidic compounds and uses thereof
08/27/2009CA2715859A1 Compounds and methods for the prevention or treatment of restenosis
08/27/2009CA2715665A1 Microparticle and pharmaceutical composition thereof
08/27/2009CA2715626A1 Sustained release poloxamer containing pharmaceutical compositions
08/27/2009CA2714939A1 Use of therapeutic peptides for the treatment and prevention of cancer
08/27/2009CA2714853A1 Selective poly-n-substituted glycine antibiotics
08/27/2009CA2709907A1 Peptide derived from neurotensin receptor 3 and use thereof in the treatment of psychiatric diseases
08/26/2009EP2093570A1 Modulating the interaction between HGF beta chain and c-met
08/26/2009EP2093294A1 Nucleotide and protein sequences of Nogo genes and methods based thereon
08/26/2009EP2093293A2 G-Protein coupled receptors
08/26/2009EP2093292A2 Inhibition of specific histone deacetylase isoforms
08/26/2009EP2093290A1 Thrombin mutant
08/26/2009EP2093235A1 Hyperglycosylated variants of interferon alfacon-1
08/26/2009EP2093233A1 Novel compositions and methods in cancer
08/26/2009EP2092938A1 Survivin-derived peptides and use thereof
08/26/2009EP2092937A2 Immunotherapeutic and immunoprophylactic reagents
08/26/2009EP2092936A2 Tamper-resistant oral opioid agonist formulations
08/26/2009EP2092834A1 Methods and compositions of sphingolipid for preventing treating microbial infections
08/26/2009EP2092069A2 Modified soluble fgf receptor fc fusions with improved biological activity
08/26/2009EP2091973A2 Binary epitope antibodies and b cell superantigen immune stimulants
08/26/2009EP2091968A2 Il-21 variants
08/26/2009EP2091965A1 Peptide vaccines for cancers expressing mphosph1 or depdc1 polypeptides
08/26/2009EP2091960A2 Peptide vaccine for influenza virus
08/26/2009EP2091959A1 Improved peptide composition
08/26/2009EP2091569A2 Targeted delivery of therapeutic agents with lyophilized matrices
08/26/2009EP2091562A1 Il- 18 vaccine for the treatment of various inflammatory conditions.
08/26/2009EP2091557A2 Improved methods and compositions for wound healing
1 ... 740 741 742 743 744 745 746 747 748 749 750 751 752 753 754 755 756 757 758 759 760 ... 3163